Merck Total Non-Operating Income/Expense 2010-2024 | MKKGY
Merck annual/quarterly total non-operating income/expense history and growth rate from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
- Merck total non-operating income/expense for the quarter ending June 30, 2024 was $-0.008B, a 90.9% decline year-over-year.
- Merck total non-operating income/expense for the twelve months ending June 30, 2024 was $-0.070B, a 66.15% decline year-over-year.
- Merck annual total non-operating income/expense for 2023 was $-0.135B, a 31.33% decline from 2022.
- Merck annual total non-operating income/expense for 2022 was $-0.197B, a 34.69% decline from 2021.
- Merck annual total non-operating income/expense for 2021 was $-0.302B, a 25.39% decline from 2020.
Merck Annual Total Non-Operating Income/Expense
(Millions of US $) |
| 2023 |
$-135 |
| 2022 |
$-197 |
| 2021 |
$-302 |
| 2020 |
$-404 |
| 2019 |
$-430 |
| 2018 |
$-314 |
| 2017 |
$-339 |
| 2016 |
$-361 |
| 2015 |
$-396 |
| 2014 |
$-273 |
| 2013 |
$-1,048 |
| 2012 |
$-1,072 |
| 2011 |
$-369 |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Total Non-Operating Income/Expense
(Millions of US $) |
| 2024-06-30 |
$-8 |
| 2024-03-31 |
$-35 |
| 2023-12-31 |
$22 |
| 2023-09-30 |
$-50 |
| 2023-06-30 |
$-83 |
| 2023-03-31 |
$-25 |
| 2022-12-31 |
$-52 |
| 2022-09-30 |
$-47 |
| 2022-06-30 |
$-60 |
| 2022-03-31 |
$-38 |
| 2021-12-31 |
$-51 |
| 2021-09-30 |
$-64 |
| 2021-06-30 |
$-114 |
| 2021-03-31 |
$-72 |
| 2020-12-31 |
$-64 |
| 2020-09-30 |
$-119 |
| 2020-06-30 |
$-113 |
| 2020-03-31 |
$-108 |
| 2019-12-31 |
$-84 |
| 2019-09-30 |
$-149 |
| 2019-06-30 |
$-69 |
| 2019-03-31 |
$-128 |
| 2018-12-31 |
$-95 |
| 2018-09-30 |
$-65 |
| 2018-06-30 |
$-78 |
| 2018-03-31 |
$-76 |
| 2017-12-31 |
$-109 |
| 2017-09-30 |
$-76 |
| 2017-06-30 |
$-78 |
| 2017-03-31 |
$-76 |
| 2016-12-31 |
$-74 |
| 2016-09-30 |
$-75 |
| 2016-06-30 |
$-137 |
| 2016-03-31 |
$-75 |
| 2015-12-31 |
$-147 |
| 2015-09-30 |
$-91 |
| 2015-06-30 |
$-45 |
| 2015-03-31 |
$-114 |
| 2014-12-31 |
$-80 |
| 2014-09-30 |
$-76 |
| 2014-06-30 |
$-69 |
| 2014-03-31 |
$-48 |
| 2013-12-31 |
$-265 |
| 2013-09-30 |
$-260 |
| 2013-06-30 |
$-266 |
| 2013-03-31 |
$-258 |
| 2012-12-31 |
|
| 2012-09-30 |
$-275 |
| 2012-06-30 |
$-284 |
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
$-167 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$-245 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
